Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02051738Phase 1Completed
Phase 1, randomised, open-label trial of mebendazole in helminthiasis (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Concentration of mebendazole in blood and urine. Started Feb 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02051738.